semaglutide controversy Weight loss drugs and compounding How 'miracle' weight‐loss semaglutide promises

In clinical trials, once-weekly subcutaneous semaglutide reduced the risk of HF outcomes compared with placebo in individuals with HF (including those with preserved ejection fraction (HFpEF), obesity or chronic kidney disease)

Glenn Lyle help patients who need surgical body contouring for the best results after medical weight loss

Gabapentin and hydrocodone can interact with various other medications, including antidepressants, muscle relaxants, and certain antihistamines, which may exacerbate side effects or diminish the effectiveness of treatment

Gut microbiota-mediated inflammation and gut permeability in patients with obesity and colorectal cancer